Skip to main content

Published locations for ASH: Daratumumab and len/dex produce high response rates in refractory myeloma

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. ASH: Daratumumab and len/dex produce high response rates in refractory myeloma

User login

  • Reset your password
  • /content/ash-daratumumab-and-len/dex-produce-high-response-rates-refractory-myeloma
  • /familypracticenews/article/104955/multiple-myeloma/ash-daratumumab-and-len/dex-produce-high-response
  • /hematologynews/article/104955/multiple-myeloma/ash-daratumumab-and-len/dex-produce-high-response
  • /internalmedicinenews/article/104955/multiple-myeloma/ash-daratumumab-and-len/dex-produce-high
  • /oncologypractice/article/104955/multiple-myeloma/ash-daratumumab-and-len/dex-produce-high-response
  • /hematology-oncology/article/104955/multiple-myeloma/ash-daratumumab-and-len/dex-produce-high
  • /internalmedicine/article/104955/multiple-myeloma/ash-daratumumab-and-len/dex-produce-high-response
  • /familymedicine/article/104955/multiple-myeloma/ash-daratumumab-and-len/dex-produce-high-response